EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prediction of major intravascular hemolysis during pulsed electric field ablation of atrial fibrillation using a pentaspline catheter

Predrag Stojadinović iD, Nicoletta Ventrella, Hana Alfredová, Dan Wichterle iD, Petr Peichl, Robert Čihák, Vanda Filová Ing, Eva Borišincová, Petr Štiavnický, Jana Hašková, Janka Franeková, Josef Kautzner

Journal of Cardiovascular Electrophysiology · 2024-12 · 35 (12) · 2405-2410

DOI: 10.1111/jce.16468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 13.10.2024. Verfasst von Predrag Stojadinović und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia. Hauptthemen laut MEDLINE: Catheter Ablation, Atrial Fibrillation, Hemolysis, Biomarkers. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Project of Ministry of Health of Czech Republic for development of research organization 00023001 (IKEM, Prague, Czech Republic), National institute for research of metabolic and cardiovascular disease Programme (EXCELES, Project No. LX22NPO5104).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pulsed electric field (PEF) has emerged as a promising energy source for catheter ablation of atrial fibrillation (AF). However, data regarding the in‐vivo effect of PEF energy on erythrocytes during AF ablation procedures are scarce. This study aimed to quantify the impact of PEF energy on erythrocyte damage during AF ablation by assessing specific hemolytic biomarkers.

Methods

A total of 60 patients (age: 68 years, males: 72%, serum creatinine: 91 µmol/L) with AF underwent catheter ablation of AF using PEF energy delivered by a multipolar pentaspline Farawave catheter (Farapulse, Boston Scientific, Inc.). Ablation beyond pulmonary vein isolation was performed at the operator's discretion. Peripheral venous blood was sampled for assessing the plasma levels of free hemoglobin (fHb), direct (conjugated) bilirubin, lactate dehydrogenase (LDH), and creatinine before, immediately after the ablation, and on the next day.

Results

Following the PEF ablation with duration of [median (interquartile range)] 75 (58, 95) min, with 74 (52, 92) applications and PVI only in 27% of patients, fHb, LDH, and direct bilirubin significantly increased, from 40 (18, 65) to 493 (327, 848) mg/L, from 3.1 (2.6, 3.6) to 6.8 (5.0, 7.9) µkat/L, and from 12 (9, 17) to 28 (16, 44) µmol/L, respectively (all p < .0001). A strong linear correlation was found between the peak fHb and the number of PEF applications ( R = 0.81, p < .001). The major hemolysis (defined as fHb >500 mg/L) was predicted by the number of PEF applications with the corresponding area under the receiver operating characteristic curve of 0.934. The optimum cut‐off value of >74 PEF applications predicted the major hemolysis with 89% sensitivity and 87% specificity.

Conclusion

Catheter ablation of AF using PEF energy delivered from a pentaspline catheter is associated with significant intravascular hemolysis. More than 74 PEF applications frequently resulted in major hemolysis. However, the critical amount of PEF energy that may cause kidney injury in susceptible patients remains to be investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Catheter AblationAtrial FibrillationHemolysisBiomarkersHumansMaleFemaleAgedMiddle AgedTreatment OutcomeCreatinineHemoglobinsCardiac CathetersPredictive Value of TestsEquipment DesignBilirubinRisk FactorsL-Lactate DehydrogenaseTime FactorsErythrocytes

Stichwörter der Autor:innen

acute kidney injuryatrial fibrillationhemolysispulsed field ablation

Substanzen

BiomarkersCreatinineHemoglobinsBilirubinL-Lactate Dehydrogenase

Autor:innen und Institutionen

  • Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia.
  • Institute of Physiology, Charles University Medical School I, Prague, Czechia.
  • Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milan, Milan, Italy.
  • Department of Biochemistry, Institute for Clinical and Experimental Medicine, Prague, Czechia.

ORCID-Profile: Predrag Stojadinović, Dan Wichterle

Förderung

  • Project of Ministry of Health of Czech Republic for development of research organization 00023001 (IKEM, Prague, Czech Republic)
  • National institute for research of metabolic and cardiovascular disease Programme (EXCELES, Project No. LX22NPO5104)

Zitieren

APA

Stojadinović, P., Ventrella, N., Alfredová, H., Wichterle, D., Peichl, P., Čihák, R., Ing, V. F., Borišincová, E., Štiavnický, P., Hašková, J., Franeková, J., & Kautzner, J. (2024). Prediction of major intravascular hemolysis during pulsed electric field ablation of atrial fibrillation using a pentaspline catheter. Journal of Cardiovascular Electrophysiology, 35(12), 2405-2410. https://doi.org/10.1111/jce.16468

Vancouver

Stojadinović P, Ventrella N, Alfredová H, Wichterle D, Peichl P, Čihák R, et al. Prediction of major intravascular hemolysis during pulsed electric field ablation of atrial fibrillation using a pentaspline catheter. Journal of Cardiovascular Electrophysiology. 2024;35(12):2405-2410. doi:10.1111/jce.16468

BibTeX
@article{Stojadinovi2024,
  author = {Stojadinović, Predrag and Ventrella, Nicoletta and Alfredová, Hana and Wichterle, Dan and Peichl, Petr and Čihák, Robert and Ing, Vanda Filová and Borišincová, Eva and Štiavnický, Petr and Hašková, Jana and Franeková, Janka and Kautzner, Josef},
  title = {Prediction of major intravascular hemolysis during pulsed electric field ablation of atrial fibrillation using a pentaspline catheter},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2024},
  volume = {35},
  number = {12},
  pages = {2405--2410},
  doi = {10.1111/jce.16468}
}
Kostenlos starten →